DNLI vs TSM
Denali Therapeutics Inc (DNLI) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
TSM (TSM) common stock.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
TSM does not have a complete income-statement cache yet.
DNLI currently screens at market cap $2.11B. TSM currently screens at market cap $0.
Not investment advice. Open the DNLI and TSM stock pages for the full models.
Not investment advice.